Skip to main content
Pearson+ LogoPearson+ Logo
Ch. 19 - The Genetics of Cancer
Klug - Essentials of Genetics 10th Edition
Klug10th EditionEssentials of GeneticsISBN: 9780135588789Not the one you use?Change textbook
Chapter 19, Problem 22

Genetic tests that detect mutations in the BRCA1 and BRCA2 tumor-suppressor genes are widely available. These tests reveal a number of mutations in these genes—mutations that have been linked to familial breast cancer. Assume that a young woman in a suspected breast cancer family takes the BRCA1 and BRCA2 genetic tests and receives negative results. That is, she does not test positive for the mutant alleles of BRCA1 or BRCA2. Can she consider herself free of risk for breast cancer?

Verified step by step guidance
1
Understand the role of BRCA1 and BRCA2 genes: These are tumor-suppressor genes, and mutations in them are known to significantly increase the risk of familial breast cancer.
Recognize what a negative test result means: A negative result indicates that the woman does not carry the specific mutations in BRCA1 or BRCA2 that the test screens for.
Consider the limitations of genetic testing: Not all mutations in BRCA1 and BRCA2 may be detected by the test, and there are other genes and environmental factors that can contribute to breast cancer risk.
Evaluate the concept of residual risk: Even with a negative test, the woman may still have a baseline or familial risk of breast cancer due to other genetic or non-genetic factors.
Conclude that a negative BRCA1 and BRCA2 test reduces but does not eliminate breast cancer risk, so she should continue regular screening and consult with a genetic counselor or healthcare provider for personalized risk assessment.

Verified video answer for a similar problem:

This video solution was recommended by our tutors as helpful for the problem above.
Video duration:
29s
Was this helpful?

Key Concepts

Here are the essential concepts you must grasp in order to answer the question correctly.

Role of BRCA1 and BRCA2 Genes

BRCA1 and BRCA2 are tumor-suppressor genes that help repair DNA damage and maintain genomic stability. Mutations in these genes can impair their function, increasing the risk of developing breast and ovarian cancers. However, not all breast cancers are caused by mutations in these genes, so their presence or absence only partially predicts cancer risk.
Recommended video:
Guided course
11:19
Segmentation Genes

Genetic Testing and Interpretation of Results

Genetic tests for BRCA1 and BRCA2 identify known mutations linked to higher cancer risk, but a negative result means no detected mutations, not zero risk. Some mutations may be unknown or undetectable, and other genetic or environmental factors can also influence cancer risk. Thus, a negative test reduces but does not eliminate the possibility of developing breast cancer.
Recommended video:
Guided course
11:35
History of Genetics

Multifactorial Nature of Breast Cancer Risk

Breast cancer risk is influenced by multiple factors including genetics, lifestyle, environment, and hormonal influences. Besides BRCA mutations, other genes and non-genetic factors contribute to risk. Therefore, even without BRCA mutations, individuals from high-risk families may still have an elevated risk due to other inherited or acquired factors.
Recommended video:
Guided course
09:46
Cancer Characteristics
Related Practice
Textbook Question

How do translocations such as the Philadelphia chromosome contribute to cancer?

770
views
Textbook Question

How do normal cells protect themselves from accumulating mutations in genes that could lead to cancer? How do cancer cells differ from normal cells in these processes?

406
views
Textbook Question

Radiotherapy (treatment with ionizing radiation) is one of the most effective current cancer treatments. It works by damaging DNA and other cellular components. In which ways could radiotherapy control or cure cancer, and why does radiotherapy often have significant side effects?

513
views
Textbook Question

As part of a cancer research project, you have discovered a gene that is mutated in many metastatic tumors. After determining the DNA sequence of this gene, you compare the sequence with those of other genes in the human genome sequence database. Your gene appears to code for an amino acid sequence that resembles sequences found in some serine proteases. Conjecture how your new gene might contribute to the development of highly invasive cancers.

557
views
Textbook Question

A study by Bose and colleagues (1998). Blood 92:3362-3367] and a previous study by Biernaux and others (1996). Bone Marrow Transplant 17:(Suppl. 3) S45–S47] showed that BCR-ABL fusion gene transcripts can be detected in 25 to 30 percent of healthy adults who do not develop chronic myelogenous leukemia (CML). Explain how these individuals can carry a fusion gene that is transcriptionally active and yet does not develop CML.

499
views